Hualan Biological Engineering Inc. (SHE:002007)
China · Delayed Price · Currency is CNY 17.10
-0.23 (-1.33%)
Aug 29, 2025, 2:45 PM CST
SHE:002007 Revenue
Hualan Biological Engineering had revenue of 930.59M CNY in the quarter ending June 30, 2025, with 7.53% growth. This brings the company's revenue in the last twelve months to 4.52B, down -16.35% year-over-year. In the year 2024, Hualan Biological Engineering had annual revenue of 4.38B, down -18.02%.
Revenue (ttm)
4.52B
Revenue Growth
-16.35%
P/S Ratio
6.91
Revenue / Employee
1.13M
Employees
4,012
Market Cap
31.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.38B | -962.68M | -18.02% |
| Dec 31, 2023 | 5.34B | 824.89M | 18.26% |
| Jan 1, 2023 | 4.52B | 80.78M | 1.82% |
| Jan 1, 2022 | 4.44B | -587.01M | -11.69% |
| Dec 31, 2020 | 5.02B | 1.32B | 35.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| WuXi AppTec | 41.90B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Aier Eye Hospital Group | 21.81B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |